Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders.

Erskine D, Taylor JP, Bakker G, Brown AJH, Tasker T, Nathan PJ.

Drug Discov Today. 2019 Sep 6. pii: S1359-6446(19)30338-1. doi: 10.1016/j.drudis.2019.08.009. [Epub ahead of print] Review.

PMID:
31499186
2.

Shock Compression of Liquid Deuterium up to 1 TPa.

Fernandez-Pañella A, Millot M, Fratanduono DE, Desjarlais MP, Hamel S, Marshall MC, Erskine DJ, Sterne PA, Haan S, Boehly TR, Collins GW, Eggert JH, Celliers PM.

Phys Rev Lett. 2019 Jun 28;122(25):255702. doi: 10.1103/PhysRevLett.122.255702.

PMID:
31347873
3.

Parkinson's disease biomarkers based on α-synuclein.

Fayyad M, Salim S, Majbour N, Erskine D, Stoops E, Mollenhauer B, El-Agnaf OMA.

J Neurochem. 2019 Sep;150(5):626-636. doi: 10.1111/jnc.14809. Epub 2019 Jul 28. Review.

PMID:
31265130
4.

Antibodies against alpha-synuclein: tools and therapies.

Vaikath NN, Hmila I, Gupta V, Erskine D, Ingelsson M, El-Agnaf OMA.

J Neurochem. 2019 Sep;150(5):612-625. doi: 10.1111/jnc.14713. Epub 2019 Jun 25. Review.

PMID:
31055836
5.

DOAC dosing in renal impairment.

Erskine D.

Drug Ther Bull. 2019 Apr;57(4):50. doi: 10.1136/dtb.2019.000013. No abstract available.

PMID:
30918002
6.

Neurodegenerative Diseases and Ageing.

Walker L, McAleese KE, Erskine D, Attems J.

Subcell Biochem. 2019;91:75-106. doi: 10.1007/978-981-13-3681-2_4. Review.

PMID:
30888650
7.

Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Erskine D, Taylor JP, Thomas A, Collerton D, McKeith I, Khundakar A, Attems J, Morris C.

Neurosci Bull. 2019 Apr;35(2):295-300. doi: 10.1007/s12264-019-00341-4. Epub 2019 Feb 6. No abstract available.

PMID:
30729454
8.

Dementia with Lewy bodies: an update and outlook.

Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I.

Mol Neurodegener. 2019 Jan 21;14(1):5. doi: 10.1186/s13024-019-0306-8. Review.

9.

Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.

McAleese KE, Graham S, Dey M, Walker L, Erskine D, Johnson M, Johnston E, Thomas AJ, McKeith IG, DeCarli C, Attems J.

Brain Pathol. 2019 May;29(3):414-424. doi: 10.1111/bpa.12685. Epub 2019 Jan 29.

PMID:
30485582
10.

Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.

Vaikath NN, Erskine D, Morris CM, Majbour NK, Vekrellis K, Li JY, El-Agnaf OMA.

Neuropathol Appl Neurobiol. 2019 Oct;45(6):597-608. doi: 10.1111/nan.12531. Epub 2018 Dec 3.

PMID:
30422353
11.

Theoretical and experimental investigation of the equation of state of boron plasmas.

Zhang S, Militzer B, Gregor MC, Caspersen K, Yang LH, Gaffney J, Ogitsu T, Swift D, Lazicki A, Erskine D, London RA, Celliers PM, Nilsen J, Sterne PA, Whitley HD.

Phys Rev E. 2018 Aug;98(2-1):023205. doi: 10.1103/PhysRevE.98.023205.

PMID:
30253522
12.

Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies.

Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM.

Mov Disord. 2018 Jul;33(6):982-991. doi: 10.1002/mds.27333. Epub 2018 Mar 23.

13.

Regional levels of physiological α-synuclein are directly associated with Lewy body pathology.

Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, Morris CM.

Acta Neuropathol. 2018 Jan;135(1):153-154. doi: 10.1007/s00401-017-1787-6. Epub 2017 Nov 13. No abstract available.

PMID:
29134319
14.

Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.

McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J.

Acta Neuropathol. 2017 Sep;134(3):459-473. doi: 10.1007/s00401-017-1738-2. Epub 2017 Jun 21.

15.

Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts.

Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J.

J Neural Transm (Vienna). 2017 Jun;124(6):671-683. doi: 10.1007/s00702-017-1702-2. Epub 2017 Mar 6.

16.

Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA.

Am J Geriatr Psychiatry. 2017 Jun;25(6):595-604. doi: 10.1016/j.jagp.2017.01.005. Epub 2017 Jan 10.

PMID:
28190674
17.

Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies.

Erskine D, Thomas AJ, Attems J, Taylor JP, McKeith IG, Morris CM, Khundakar AA.

Mov Disord. 2017 Mar;32(3):414-422. doi: 10.1002/mds.26887. Epub 2017 Jan 6.

PMID:
28059471
18.

TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.

McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J.

Brain Pathol. 2017 Jul;27(4):472-479. doi: 10.1111/bpa.12424. Epub 2016 Aug 24.

PMID:
27495267
19.

Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations.

Khundakar AA, Hanson PS, Erskine D, Lax NZ, Roscamp J, Karyka E, Tsefou E, Singh P, Cockell SJ, Gribben A, Ramsay L, Blain PG, Mosimann UP, Lett DJ, Elstner M, Turnbull DM, Xiang CC, Brownstein MJ, O'Brien JT, Taylor JP, Attems J, Thomas AJ, McKeith IG, Morris CM.

Acta Neuropathol Commun. 2016 Jun 30;4(1):66. doi: 10.1186/s40478-016-0334-3.

20.

Ghost fringe removal techniques using Lissajous data presentation.

Erskine DJ, Eggert JH, Celliers PM, Hicks DG.

Rev Sci Instrum. 2016 Mar;87(3):033106. doi: 10.1063/1.4943563.

PMID:
27036757
21.

Stereological approaches to dementia research using human brain tissue.

Erskine D, Khundakar AA.

J Chem Neuroanat. 2016 Oct;76(Pt B):73-81. doi: 10.1016/j.jchemneu.2016.01.004. Epub 2016 Jan 14.

PMID:
26777894
22.

Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies.

Erskine D, Taylor JP, Firbank MJ, Patterson L, Onofrj M, O'Brien JT, McKeith IG, Attems J, Thomas AJ, Morris CM, Khundakar AA.

Neuropathol Appl Neurobiol. 2016 Jun;42(4):366-76. doi: 10.1111/nan.12249. Epub 2015 Jun 2.

23.

Implementation and impact of an extended-hours service in mental health care: lessons learned.

Erskine D, Baumgartner B, Patterson S.

Aust Health Rev. 2015 Nov;39(5):508-513. doi: 10.1071/AH15007.

PMID:
25844660
24.

Holographic and time-resolving ability of pulse-pair two-dimensional velocity interferometry.

Erskine DJ, Smith RF, Bolme CA, Ali SJ, Celliers PM, Collins GW.

Rev Sci Instrum. 2014 Jun;85(6):063115. doi: 10.1063/1.4884880.

PMID:
24985807
25.

Two-dimensional imaging velocity interferometry: data analysis techniques.

Erskine DJ, Smith RF, Bolme CA, Celliers PM, Collins GW.

Rev Sci Instrum. 2012 Apr;83(4):043116. doi: 10.1063/1.4704840.

PMID:
22559524
26.

A high-resolution two-dimensional imaging velocimeter.

Celliers PM, Erskine DJ, Sorce CM, Braun DG, Landen OL, Collins GW.

Rev Sci Instrum. 2010 Mar;81(3):035101. doi: 10.1063/1.3310076.

PMID:
20370207
27.

Ventricular fibrillation secondary to itraconazole induced hypokalaemia.

Nelson MR, Smith D, Erskine D, Gazzard BG.

J Infect. 1993 May;26(3):348. No abstract available.

PMID:
8389392
28.

Treatment with corticosteroids--a risk factor for the development of clinical cytomegalovirus disease in AIDS.

Nelson MR, Erskine D, Hawkins DA, Gazzard BG.

AIDS. 1993 Mar;7(3):375-8.

PMID:
8097096
29.

Electronic energy gap of molecular hydrogen from electrical conductivity measurements at high shock pressures.

Nellis WJ, Mitchell AC, McCandless PC, Erskine DJ, Weir ST.

Phys Rev Lett. 1992 May 11;68(19):2937-2940. No abstract available.

PMID:
10045533
30.

Wasted drugs in HIV infections and AIDS.

Asboe D, Daniels D, Erskine D, Boag FC.

BMJ. 1992 Feb 22;304(6825):508-9. No abstract available.

31.

Comparison of nebuliser efficiency for aerosolizing pentamidine.

Smith D, Erskine D, Steele J, Hills D, Gazzard B.

J Pharm Pharmacol. 1992 Jan;44(1):7-9.

PMID:
1350636
32.
33.

Transposon mutagenesis in Proteus mirabilis.

Belas R, Erskine D, Flaherty D.

J Bacteriol. 1991 Oct;173(19):6289-93.

34.

The use of drugs in patients with gastrointestinal manifestations of AIDS.

Erskine D.

Baillieres Clin Gastroenterol. 1990 Jun;4(2):563-85. Review. No abstract available.

PMID:
2282390
35.

Superconductivity and phase transitions in compressed Si to 45 GPa.

Erskine D, Yu PY, Chang KJ, Cohen ML.

Phys Rev Lett. 1986 Nov 24;57(21):2741-2744. No abstract available.

PMID:
10033849
36.

Dependence of superconducting transition temperature on pressure in primitive hexagonal Si.

Erskine D, Yu PY.

Phys Rev Lett. 1986 Jun 23;56(25):2770. No abstract available.

PMID:
10033088
37.

Melatonin and behavioral thermoregulation in the turtle, Terrapene carolina triunguis.

Erskine DJ, Hutchison VH.

Physiol Behav. 1981 Jun;26(6):991-4. No abstract available.

PMID:
7197033
38.

Melatonin and chlorpromazine: thermal selection in the mudpuppy, Necturus maculosus.

Hutchison VH, Black JJ, Erskine D.

Life Sci. 1979 Aug 6;25(6):527-30. No abstract available.

PMID:
491847
39.

Lymphogranuloma venereum; a review of 61 cases.

ERSKINE D.

Br J Vener Dis. 1958 Sep;34(3):163-5. No abstract available.

40.

Epidermophytosis.

ERSKINE D.

Med Press. 1949 Apr 13;221(15):357-61. No abstract available.

PMID:
18117338
41.

Parapsoriasis en plaques treated with calciferol.

BARBER HW, ERSKINE D.

Proc R Soc Med. 1948 Nov;41(11):755. No abstract available.

42.

THE TREND OF ANTISYPHILITIC TREATMENT.

Erskine D.

Br J Vener Dis. 1944 Jun;20(2):73-7. No abstract available.

43.

Sulphonamide Intolerance.

Erskine D.

Br J Vener Dis. 1939 Oct;15(4):260-8. No abstract available.

44.

Dermatitis from Sulphonamide Compounds.

Erskine D.

Br Med J. 1939 Jul 15;2(4097):104-7. No abstract available.

Supplemental Content

Loading ...
Support Center